Monitoring long-term treatments in multiple sclerosis

被引:2
|
作者
Filippi, Massimo [1 ]
Rocca, Maria A. [1 ]
机构
[1] Sci Inst & Univ Hosp San Raffaele, Inst Expt Neurol, Div Neurosci, Neuroimaging Res Unit, I-20132 Milan, Italy
关键词
OUTCOMES;
D O I
10.1038/nrneurol.2010.88
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients with relapsing-remitting multiple sclerosis have been shown to benefit from disease-modifying treatments over prolonged periods. More focus should now be placed on monitoring the long-term evolution of this disease (making use of tools such as MRI), alongside the patients' response and adherence to such treatments.
引用
收藏
页码:421 / 422
页数:3
相关论文
共 50 条
  • [41] Long-term trajectories of ambulatory impairment in multiple sclerosis
    Gunzler, Douglas D.
    De Nadai, Alessandro S.
    Miller, Deborah M.
    Ontaneda, Daniel
    Briggs, Farren B. S.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (10) : 1282 - 1295
  • [42] Long-term treatment of multiple sclerosis with IgG immunotherapy
    Schuller, E
    Lambin, P
    Deloche, G
    PATHOLOGIE BIOLOGIE, 1996, 44 (08): : 710 - 715
  • [43] Long-term effects of intrathecal baclofen in multiple sclerosis
    Natale, Massimo
    D'Oria, Salvatore
    Nero, Veronica Venera
    Squillante, Eleonora
    Gentile, Marisa
    Rotondo, Michele
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 143 : 121 - 125
  • [44] LONG-TERM EFFICACY OF OCRELIZUMAB IN RELAPSING MULTIPLE SCLEROSIS
    Giovannoni, Gavin
    Hauser, Stephen L.
    Brochet, Bruno
    Montalban, Xavier
    Naismith, Robert T.
    Wolinsky, Jerry S.
    Hubeaux, Stanislas
    Mehta, Lahar
    Model, Fabian
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
  • [45] Long-term effects of glatiramer acetate in multiple sclerosis
    Brochet, B.
    REVUE NEUROLOGIQUE, 2008, 164 (11) : 917 - 926
  • [46] Interferon-β for multiple sclerosis:: Long-term benefits?
    Rudick, Richard A.
    Cutter, Gary
    ANNALS OF NEUROLOGY, 2007, 61 (04) : 283 - 285
  • [47] Multiple sclerosis relapses contribute to long-term disability
    Scott, Thomas F.
    Diehl, Daniel
    Elmalik, Wisam
    Gettings, Edward J.
    Hackett, Chris
    Schramke, Carol J.
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 140 (05): : 336 - 341
  • [48] Estimating the long-term effect of drugs in multiple sclerosis
    Cordioli, C.
    Rasia, S.
    Gallo, F.
    Capra, R.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 108 - 109
  • [49] LONG-TERM CARE ISSUES IN MULTIPLE-SCLEROSIS
    FRANKEL, D
    REHABILITATION LITERATURE, 1984, 45 (9-10) : 282 - 285